pharma · Diabetes · Congenital Bleeding Disorder
Novo Nordisk A/S
Novo Nordisk A/S clinical programs — 25 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Novo Alle, Bagsværd, 2880, DK
- Founded
- 1923
- Employees
- 63,033
- Programs
- 40
- Drugs
- 46
- Patents
- 0
Novo Nordisk A/S projects
25 ClinicalTrials.gov programs sponsored by Novo Nordisk A/S.
Novo Nordisk A/S has 25 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CHRD 2419
Novo Nordisk A/S
Cardiorespiratory arrest at birth in full-term newborns
1 trial -
Cagrilintide
Novo Nordisk A/S
Overweight
1 trial -
Concizumab
Novo Nordisk A/S
Haemophilia A With Inhibitors
1 trial -
Concizumab
Novo Nordisk A/S
Haemophilia A Without Inhibitors
1 trial -
EF-41/KEYNOTE D58
Novo Nordisk A/S
Newly diagnosed Glioblastoma
1 trial -
Faster-acting insulin aspart
Novo Nordisk A/S
Diabetes
1 trial -
Insulin degludec/insulin aspart
Novo Nordisk A/S
Diabetes
1 trial -
Insulin icodec
Novo Nordisk A/S
Diabetes, Type 2
1 trial -
NNC0487-0111
Novo Nordisk A/S
Obesity
1 trial -
Oral semaglutide
Novo Nordisk A/S
Diabetes Mellitus, Type 2
1 trial -
Semaglutide
Novo Nordisk A/S
Overweight
1 trial -
Somapacitan
Novo Nordisk A/S
Growth Hormone Deficiency in Children
2 trials -
Tecentriq 840 mg concentrate for solution for infusion
Novo Nordisk A/S
Metastatic pancreatic ductal adenocarcinoma (mPDAC)
1 trial -
UVEDOSE 100 000 UI, solution buvable en ampoule
Novo Nordisk A/S
Thyroidectomy is a common operation. Transient postoperative hypocalcemia is the main complication, resulting in clinical discomfort for patients, longer hospital stays and increased perioperative cost. Cholecalciferol is used to supplement vitamin D deficiency. We suppose that systematic pre-operative supplementation with cholecalciferol would allow a faster and more appropriate response to post-operative hypocalcemia
1 trial -
Ziltivekimab
Novo Nordisk A/S
Heart Failure
1 trial -
biphasic insulin aspart
Novo Nordisk A/S
Diabetes
1 trial -
eptacog alfa (activated)
Novo Nordisk A/S
Acquired Bleeding Disorder
1 trial -
insulin degludec
Novo Nordisk A/S
Diabetes
2 trials -
liraglutide
Novo Nordisk A/S
Diabetes
2 trials -
liraglutide
Novo Nordisk A/S
Metabolism and Nutrition Disorder
1 trial -
nonacog beta pegol
Novo Nordisk A/S
Congenital Bleeding Disorder
1 trial -
rosiglitazone
Novo Nordisk A/S
Diabetes
1 trial -
semaglutide
Novo Nordisk A/S
Diabetes
4 trials -
somapacitan
Novo Nordisk A/S
Growth Hormone Disorder
1 trial -
turoctocog alfa pegol
Novo Nordisk A/S
Congenital Bleeding Disorder
2 trials
Frequently asked questions
How many clinical projects does Novo Nordisk A/S have?
25 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.